| For: | Cardinale V, Semeraro R, Torrice A, Gatto M, Napoli C, Bragazzi MC, Gentile R, Alvaro D. Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol 2010; 2(11): 407-416 [PMID: 21160904 DOI: 10.4251/wjgo.v2.i11.407] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v2/i11/407.htm |
| Number | Citing Articles |
| 1 |
Samantha M. Ruff, Sameek Roychowdhury, Timothy M. Pawlik. The future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for cholangiocarcinoma. Expert Opinion on Pharmacotherapy 2023; 24(7) doi: 10.1080/14656566.2023.2202814
|
| 2 |
Tzu-I Chen, Ming-Huang Chen, Szu-Ching Yin, Chih-Jo Lin, Tram Kim Lam, Chia-Wei Huang, Yi-Ting Chen, Xia-Rong Liu, Yun-Zheng Gao, Wan-Lun Hsu, Hsuan-Yu Chen, Ta-Sen Yeh, Jill Koshiol, Mei-Hsuan Lee. Associations between metabolic syndrome and cholangiocarcinoma risk: A large-scale population-based cohort study. Hepatology 2026; 83(2) doi: 10.1097/HEP.0000000000001312
|
| 3 |
Guido Carpino, Anastasia Renzi, Antonio Franchitto, Vincenzo Cardinale, Paolo Onori, Lola Reid, Domenico Alvaro, Eugenio Gaudio, Toru Hosoda. Stem/Progenitor Cell Niches Involved in Hepatic and Biliary Regeneration. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/3658013
|
| 4 |
Gavin Low, Tyler Pfanner, Xu Jing Qian, Ali Ramji, Karim Samji, Mitchell P. Wilson. LR-M for CT/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective. Abdominal Radiology 2025; 51(3) doi: 10.1007/s00261-025-05132-2
|
| 5 |
Georg Wiltberger, Felix Krenzien, Christian Benzing, Georgi Atanasov, Fritz Klein, Hans-Michael Hau, Linda Feldbrügge, Johann Pratschke, Moritz Schmelzle, Sven Jonas. Prognostic Accuracy of the Seventh Edition of the TNM Classification Compared with the Fifth and Sixth Edition for Distal Cholangiocarcinoma. Annals of Surgical Oncology 2016; 23(4) doi: 10.1245/s10434-015-4999-9
|
| 6 |
Stefania Curti, Mena Gallo, Daniela Ferrante, Francesca Bella, Lorenza Boschetti, Veronica Casotto, Marcello Ceppi, Daniela Cervino, Lucia Fazzo, Ugo Fedeli, Paolo Giorgi Rossi, Lucia Giovannetti, Paolo Girardi, Cecilia Lando, Enrica Migliore, Lucia Miligi, Enrico Oddone, Vincenza Perlangeli, Roberta Pernetti, Sara Piro, Cinzia Storchi, Rosario Tumino, Amerigo Zona, Manuel Zorzi, Giovanni Brandi, Stefano Ferretti, Corrado Magnani, Alessandro Marinaccio, Stefano Mattioli. Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study. La Medicina del Lavoro 2024; 115(2) doi: 10.23749/mdl.v115i2.14649
|
| 7 |
Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2012; 9(1) doi: 10.1038/nrgastro.2011.222
|
| 8 |
Xi-Hsuan Lin, Jiing-Chyuan Luo. The risk factors and prognostic factors of intrahepatic cholangiocarcinoma. Journal of the Chinese Medical Association 2017; 80(3) doi: 10.1016/j.jcma.2016.12.001
|
| 9 |
Carolyn Tsung, Patrick L. Quinn, Aslam Ejaz. Management of Intrahepatic Cholangiocarcinoma: A Narrative Review. Cancers 2024; 16(4) doi: 10.3390/cancers16040739
|
| 10 |
|
| 11 |
Mami Hamaoka, Kazuto Kozaka, Osamu Matsui, Takahiro Komori, Takashi Matsubara, Norihide Yoneda, Kotaro Yoshida, Dai Inoue, Azusa Kitao, Wataru Koda, Toshifumi Gabata, Satoshi Kobayashi. Early detection of intrahepatic cholangiocarcinoma. Japanese Journal of Radiology 2019; 37(10) doi: 10.1007/s11604-019-00860-0
|
| 12 |
Yoshiyuki Tagayasu, Rin Yamada, Kosuke Kanemitsu, Yoshihiko Kondo, Yukio Fujiwara, Takumi Tanizaki, Rumi Itoyama, Yuki Kitano, Hiromitsu Hayashi, Yoshihiro Komohara, Masaaki Iwatsuki. Increased Infiltration of Tissue-Resident Memory T Cells Predicts a Good Response to Anti-PD-L1 Immunotherapy in Extrahepatic Cholangiocarcinoma. Pathobiology 2025; 93(1) doi: 10.1159/000547222
|
| 13 |
VINCENT ZIMMER, AKSANA HÖBLINGER, FLORENTINA MIHALACHE, GUNTER ASSMANN, MONICA ACALOVSCHI, FRANK LAMMERT. Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility. Oncology Letters 2012; 4(1) doi: 10.3892/ol.2012.680
|
| 14 |
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Letters 2016; 379(2) doi: 10.1016/j.canlet.2016.02.038
|
| 15 |
Katiuscha Merath, Rittal Mehta, J. Madison Hyer, Fabio Bagante, Kota Sahara, Sorin Alexandrescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Matthew J. Weiss, Todd W. Bauer, Feng Shen, George A. Poultsides, Olivier Soubrane, Guillaume Martel, B. Groot Koerkamp, Alfredo Guglielmi, Endo Itaru, Aslam Ejaz, Timothy M. Pawlik. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis. European Journal of Surgical Oncology 2019; 45(6) doi: 10.1016/j.ejso.2019.03.004
|
| 16 |
Wellington Andraus, Francisco Tustumi, José Donizeti de Meira Junior, Rafael Soares Nunes Pinheiro, Daniel Reis Waisberg, Liliana Ducatti Lopes, Rubens Macedo Arantes, Vinicius Rocha Santos, Rodrigo Bronze de Martino, Luiz Augusto Carneiro D’Albuquerque. Molecular Profile of Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences 2023; 25(1) doi: 10.3390/ijms25010461
|
| 17 |
Mackenzie Owen, Mina S. Makary, Eliza W. Beal. Locoregional Therapy for Intrahepatic Cholangiocarcinoma. Cancers 2023; 15(8) doi: 10.3390/cancers15082384
|
| 18 |
Fatemeh Vatankhah, Neda Salimi, Amirreza Khalaji, Behzad Baradaran. Immune checkpoints and their promising prospect in cholangiocarcinoma treatment in combination with other therapeutic approaches. International Immunopharmacology 2023; 114 doi: 10.1016/j.intimp.2022.109526
|
| 19 |
Yang Xin-wei, Li Liang, Hou Guo-jun, Yan Xin-zhou, Xu Qin-guo, Chen Lei, Zhang Bao-hua, Shen Feng. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Oncotarget 2017; 8(5) doi: 10.18632/oncotarget.13846
|
| 20 |
Vincenza Granata, Roberta Fusco, Federica De Muzio, Carmen Cutolo, Francesca Grassi, Maria Chiara Brunese, Igino Simonetti, Orlando Catalano, Michela Gabelloni, Silvia Pradella, Ginevra Danti, Federica Flammia, Alessandra Borgheresi, Andrea Agostini, Federico Bruno, Pierpaolo Palumbo, Alessandro Ottaiano, Francesco Izzo, Andrea Giovagnoni, Antonio Barile, Nicoletta Gandolfo, Vittorio Miele. Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence. Biology 2023; 12(2) doi: 10.3390/biology12020213
|
| 21 |
. 2016; doi: 10.70675/198f440cze4d7z4026z9b1ezfe22b7fe302c
|
| 22 |
|
| 23 |
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014. Annals of Hepatology 2018; 17(2) doi: 10.5604/01.3001.0010.8659
|
| 24 |
Charupong Saengboonmee, Sumalee Obchoei, Kanlayanee Sawanyawisuth, Sopit Wongkham. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice. Expert Review of Anticancer Therapy 2023; 23(5) doi: 10.1080/14737140.2023.2203386
|
| 25 |
Paola Bertuccio, Matteo Malvezzi, Greta Carioli, Dana Hashim, Paolo Boffetta, Hashem B. El-Serag, Carlo La Vecchia, Eva Negri. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. Journal of Hepatology 2019; 71(1) doi: 10.1016/j.jhep.2019.03.013
|
| 26 |
Jhang Ho Pak, Jimin Shin, In-Sung Song, Sungbo Shim, Sung-Wuk Jang. Clonorchis sinensis excretory–secretory products regulate migration and invasion in cholangiocarcinoma cells via extracellular signal-regulated kinase 1/2/nuclear factor-κB-dependent matrix metalloproteinase-9 expression. International Journal for Parasitology 2017; 47(1) doi: 10.1016/j.ijpara.2016.10.004
|
| 27 |
Yongjun Liu, Matthew M. Yeh. Bile duct dysplasia and associated invasive carcinoma: clinicopathological features, diagnosis, and practical challenges. Human Pathology 2023; 132 doi: 10.1016/j.humpath.2022.06.012
|
| 28 |
M. Casper, M. Acalovschi, F. Lammert, V. Zimmer. The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer. Familial Cancer 2014; 13(2) doi: 10.1007/s10689-014-9699-2
|
| 29 |
Nina Barner‐Rasmussen, Eero Pukkala, Kishor Hadkhale, Martti Färkkilä. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland. United European Gastroenterology Journal 2021; 9(10) doi: 10.1002/ueg2.12154
|
| 30 |
Vincenzo Cardinale, Yunfang Wang, Guido Carpino, Cai-Bin Cui, Manuela Gatto, Massimo Rossi, Pasquale Bartolomeo Berloco, Alfredo Cantafora, Eliane Wauthier, Mark E. Furth, Luca Inverardi, Juan Dominguez-Bendala, Camillo Ricordi, David Gerber, Eugenio Gaudio, Domenico Alvaro, Lola Reid. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 2010; 54(6) doi: 10.1002/hep.24590
|
| 31 |
Guanwu Wang, Lara Rosaline Heij, Dong Liu, Edgar Dahl, Sven Arke LANG, Tom Florian Ulmer, Tom LUEDDE, Ulf Peter Neumann, Jan Bednarsch. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review. Cancers 2022; 14(23) doi: 10.3390/cancers14235969
|
| 32 |
Tae Kyoung Kim, Korosh Khalili, Hyun-Jung Jang. Multislice-CT of the Abdomen. Medical Radiology 2011; doi: 10.1007/174_2011_409
|
| 33 |
Chiara Losquadro, Silvia Conforto, Maurizio Schmid, Gaetano Giunta, Marco Rengo, Vincenzo Cardinale, Guido Carpino, Andrea Laghi, Ana Lleo, Riccardo Muglia, Ezio Lanza, Guido Torzilli. Computer Analysis of Images and Patterns. Lecture Notes in Computer Science 2021; 13052 doi: 10.1007/978-3-030-89128-2_23
|
| 34 |
Vania Cruz-Ramón, Paulina Chinchilla-López, Oscar Ramírez-Pérez, Xingshun Qi, Nahum Méndez-Sánchez. The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers. Annals of Hepatology 2018; 17(1) doi: 10.5604/01.3001.0010.7531
|
| 35 |
Yun-Jau Chang, Yao-Jen Chang, Li-Ju Chen. Prognostic factors in patients with intrahepatic cholangiocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70124-z
|
| 36 |
Rihyeon Kim, Jeong Min Lee, Cheong-Il Shin, Eun Sun Lee, Jeong Hee Yoon, Ijin Joo, Seong Ho Kim, Inpyeong Hwang, Joon Koo Han, Byung Ihn Choi. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. European Radiology 2016; 26(6) doi: 10.1007/s00330-015-4005-8
|
| 37 |
Qunfeng Wu, Marda Jorgensen, Joanna Song, Junmei Zhou, Chen Liu, Liya Pi. Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/2313850
|
| 38 |
Pimradasiri Srijiwangsa, Saranyoo Ponnikorn, Kesara Na-Bangchang. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. BMC Pharmacology and Toxicology 2018; 19(1) doi: 10.1186/s40360-018-0223-4
|
| 39 |
Anthony B. El-Khoueiry, Cathryn J. Rankin, Edgar Ben-Josef, Heinz-Josef Lenz, Philip J. Gold, R. Darryl Hamilton, Rangaswamy Govindarajan, Cathy Eng, Charles D. Blanke. SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma. Investigational New Drugs 2012; 30(4) doi: 10.1007/s10637-011-9719-0
|
| 40 |
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014. Annals of Hepatology 2018; 17(4) doi: 10.5604/01.3001.0012.0929
|
| 41 |
Zhenliang QU, Naiqiang CUI, Mingfang QIN, Xianzhong WU. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas. Asia-Pacific Journal of Clinical Oncology 2012; 8(1) doi: 10.1111/j.1743-7563.2011.01466.x
|
| 42 |
JINGHUI YANG, QIWEI YANG, SHAN YU, XUEWEN ZHANG. Evaluation and validation of suitable reference genes for reverse transcription-quantitative polymerase chain reaction studies in cholangiocarcinoma patients and cell lines. Oncology Letters 2016; 11(4) doi: 10.3892/ol.2016.4232
|
| 43 |
Francesca Saffioti, Vasileios K Mavroeidis. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World Journal of Gastrointestinal Oncology 2021; 13(10): 1336-1366 doi: 10.4251/wjgo.v13.i10.1336
|
| 44 |
Fabio Bagante, Gaya Spolverato, Alessandro Cucchetti, Faiz Gani, Irinel Popescu, Andrea Ruzzenente, Hugo P. Marques, Luca Aldrighetti, T. Clark Gamblin, Shishir K. Maithel, Charbel Sandroussi, Todd W. Bauer, Feng Shen, George A. Poultsides, James Wallis Marsh, Alfredo Guglielmi, Timothy M. Pawlik. Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis. Surgery 2016; 160(1) doi: 10.1016/j.surg.2016.01.023
|
| 45 |
Richard A. Burkhart, Daniel A. Laheru, Joseph M. Herman, Timothy M. Pawlik. Multidisciplinary management and the future of treatment in cholangiocarcinoma. Expert Opinion on Orphan Drugs 2016; 4(3) doi: 10.1517/21678707.2016.1130618
|
| 46 |
Luca Fabris, Domenico Alvaro. The prognosis of perihilar cholangiocarcinoma after radical treatments. Hepatology 2012; 56(3) doi: 10.1002/hep.25808
|
| 47 |
Giovanni Brandi, Stefania Di Girolamo, Andrea Farioli, Francesco de Rosa, Stefania Curti, Antonio Daniele Pinna, Giorgio Ercolani, Francesco Saverio Violante, Guido Biasco, Stefano Mattioli. Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis. Cancer Causes & Control 2013; 24(5) doi: 10.1007/s10552-013-0167-3
|
| 48 |
Inês Tavares, Ricardo Martins, Ilda Patrícia Ribeiro, Luísa Esteves, Francisco Caramelo, Ana Margarida Abrantes, Rita Neves, Rui Caetano-Oliveira, Maria Filomena Botelho, Joana Barbosa de Melo, Dulce Diogo, José Guilherme Tralhão, Isabel Marques Carreira. Development of a genomic predictive model for cholangiocarcinoma using copy number alteration data. Journal of Clinical Pathology 2022; 75(4) doi: 10.1136/jclinpath-2020-207346
|
| 49 |
David Tougeron, Ginette Fotsing, Veronique Barbu, Michel Beauchant. ABCB4/MDR3 gene mutations and cholangiocarcinomas. Journal of Hepatology 2012; 57(2) doi: 10.1016/j.jhep.2012.01.025
|
| 50 |
Shiyao Zhang, You Cui, Xinyu Zhao, Qi Zhang, Chunqiang Li, Qianpeng Huang, Gang Liu. Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.950335
|
| 51 |
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, Eleni-Myrto Trifylli, Dimitris Liapopoulos, Dimitra Korakaki, Evangelos Koustas, Michalis Katsimpoulas, Michalis V. Karamouzis. Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma. Cancers 2025; 17(3) doi: 10.3390/cancers17030555
|
| 52 |
Zhiqiang Chen, Liyong Pu, Wen Gao, Long Zhang, Guoyong Han, Qin Zhu, Xiangcheng Li, Jindao Wu, Xuehao Wang. Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma. Oncotarget 2017; 8(17) doi: 10.18632/oncotarget.16330
|
| 53 |
Eva Braunwarth, Stefan Stättner, Margot Fodor, Benno Cardini, Thomas Resch, Rupert Oberhuber, Daniel Putzer, Reto Bale, Manuel Maglione, Christian Margreiter, Stefan Schneeberger, Dietmar Öfner, Florian Primavesi. Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma. European Surgery 2018; 50(3) doi: 10.1007/s10353-018-0537-x
|
| 54 |
Wangyang Chen, Dongchao Xu, Qiang Liu, Yirong Wu, Yu Wang, Jianfeng Yang. Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology. Biomedicine & Pharmacotherapy 2023; 162 doi: 10.1016/j.biopha.2023.114697
|
| 55 |
Gokmen Aktas, Tulay Kus, Ayhan Balkan, Taylan Metin, Murat Taner Gulsen, Huseyin Abali. Prognostic factors in patients with advanced extrahepatic cholangiocarcinoma. Medicine 2019; 98(8) doi: 10.1097/MD.0000000000014556
|
| 56 |
Sarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, Cedric Chuan Young Ng, Jason Yongsheng Chan, Vikneswari Rajasegaran, Tse Hui Lim, Kiat Hon Lim, Su Pin Choo, Simona Dima, Irinel Popescu, Dan G. Duda, Veerapol Kukongviriyapan, Narong Khuntikeo, Chawalit Pairojkul, Steven G. Rozen, Patrick Tan, Bin Tean Teh. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma. JCO Global Oncology 2020; (6) doi: 10.1200/GO.20.00030
|
| 57 |
Mathew Vithayathil, Shahid A. Khan. Current epidemiology of cholangiocarcinoma in Western countries. Journal of Hepatology 2022; 77(6) doi: 10.1016/j.jhep.2022.07.022
|
| 58 |
Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt. MacSween's Pathology of the Liver. 2012; doi: 10.1016/B978-0-7020-3398-8.00006-4
|
| 59 |
Habiba Kamal, Omid Sadr‐Azodi, Lars Engstrand, Nele Brusselaers. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population‐Based Cohort Study. Hepatology 2021; 74(4) doi: 10.1002/hep.31914
|
| 60 |
Yuyan Han, Sharon DeMorrow, Pietro Invernizzi, Qing Jing, Shannon Glaser, Anastasia Renzi, Fanyin Meng, Julie Venter, Francesca Bernuzzi, Mellanie White, Heather Francis, Ana Lleo, Marco Marzioni, Paolo Onori, Domenico Alvaro, Guido Torzilli, Eugenio Gaudio, Gianfranco Alpini. Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(4) doi: 10.1152/ajpgi.00118.2011
|
| 61 |
Judith I. Wyatt. Cholangiocarcinoma – new concepts and classifications. Diagnostic Histopathology 2011; 17(12) doi: 10.1016/j.mpdhp.2011.10.005
|
| 62 |
Eva Sticova, Milan Jirsa. ABCB4 disease: Many faces of one gene deficiency. Annals of Hepatology 2020; 19(2) doi: 10.1016/j.aohep.2019.09.010
|
| 63 |
Muhammad Musaab Munir, Samantha M. Ruff, Yutaka Endo, Henrique A. Lima, Laura Alaimo, Zorays Moazzam, Chanza Shaikh, Timothy M. Pawlik. Does Adjuvant Therapy Benefit Low-Risk Resectable Cholangiocarcinoma? An Evaluation of the NCCN Guidelines. Journal of Gastrointestinal Surgery 2023; 27(3) doi: 10.1007/s11605-022-05558-9
|
| 64 |
Alyssa M. Krasinskas. Cholangiocarcinoma. Surgical Pathology Clinics 2018; 11(2) doi: 10.1016/j.path.2018.02.005
|
| 65 |
Maurizio Romano, Francesco De Francesco, Enrico Gringeri, Antonio Giordano, Giuseppe A. Ferraro, Marina Di Domenico, Umberto Cillo. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?. Journal of Cellular Physiology 2016; 231(4) doi: 10.1002/jcp.25190
|
| 66 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; doi: 10.1002/9781119756422.ch17
|
| 67 |
Giuseppe Tonini, Michele Iuliani, Giulia Ribelli, Sonia Simonetti, Francesco Pantano. Practical Medical Oncology Textbook. UNIPA Springer Series 2021; doi: 10.1007/978-3-030-56051-5_41
|
| 68 |
Qiao Wu, Xiao-Dong He, Lan Yu, Wei Liu, Lian-Yuan Tao. The Metabolic Syndrome and Risk Factors for Biliary Tract Cancer: A Case-control Study in China. Asian Pacific Journal of Cancer Prevention 2012; 13(5) doi: 10.7314/APJCP.2012.13.5.1963
|
| 69 |
R. A. Budinsky, D. Schrenk, T. Simon, M. Van den Berg, J. F. Reichard, J. B. Silkworth, L. L. Aylward, A. Brix, T. Gasiewicz, N. Kaminski, G. Perdew, T. B. Starr, N. J. Walker, J. C. Rowlands. Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study. Critical Reviews in Toxicology 2014; 44(1) doi: 10.3109/10408444.2013.835787
|
| 70 |
Alexandra W. Acher, Alessandro Paro, Ahmed Elfadaly, Diamantis Tsilimigras, Timothy M. Pawlik. Intrahepatic Cholangiocarcinoma: A Summative Review of Biomarkers and Targeted Therapies. Cancers 2021; 13(20) doi: 10.3390/cancers13205169
|
| 71 |
Madhumita Premkumar, Devaraja Rangegowda, Tanmay Vyas, Shrruti Grover, Y K Joshi, Chhagan Sharma, Amrish Sahney. Cholangicarcinoma Presenting as a Sister Mary Joseph Nodule. ACG Case Reports Journal 2016; 3(1) doi: 10.14309/crj.2016.52
|
| 72 |
Ethan Kai Jun Tham, Ryan Yanzhe Lim, Benjamin Koh, Darren Jun Hao Tan, Cheng Han Ng, Michelle Law, Elina Cho, Nicole Shu Ying Tang, Claire Shiying Tan, Benedix Kuan Loo Sim, En Ying Tan, Wen Hui Lim, Mei Chin Lim, Toru Nakamura, Pojsakorn Danpanichkul, Sakkarin Chirapongsathorn, Karn Wijarnpreecha, Hirokazu Takahashi, Asahiro Morishita, Ming-Hua Zheng, Alfred Kow, Mark Muthiah, Jia Hao Law, Daniel Q Huang. Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis. Clinical Gastroenterology and Hepatology 2025; 23(10) doi: 10.1016/j.cgh.2024.09.028
|
| 73 |
Vartika Agrawal, Yeshwant Lamture, Sangeeta Totade. A Typical Case of an Atypical Disease: Klatskin Tumor. Cureus 2022; doi: 10.7759/cureus.28782
|
| 74 |
Mina Komuta. Histological Heterogeneity of Primary Liver Cancers: Clinical Relevance, Diagnostic Pitfalls and the Pathologist’s Role. Cancers 2021; 13(12) doi: 10.3390/cancers13122871
|
| 75 |
Özgür ÇAKIR. Ultrason Eşliğinde Perkütan Yolla Yapılan Karaciğer Biyopsi Uygulaması: Kocaeli Üniversitesi Girişimsel Radyoloji Deneyimi. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 2021; 7(1) doi: 10.30934/kusbed.749910
|
| 76 |
Angela Djanani. Innovative therapeutic concepts for biliary tumors. memo - Magazine of European Medical Oncology 2024; 17(1) doi: 10.1007/s12254-023-00956-4
|
| 77 |
Keun Soo Ahn, Koo Jeong Kang. Molecular heterogeneity in intrahepatic cholangiocarcinoma. World Journal of Hepatology 2020; 12(12): 1148-1157 doi: 10.4254/wjh.v12.i12.1148
|
| 78 |
Ekaterina Petrova, Felix Rückert, Sebastian Zach, YinFeng Shen, Jürgen Weitz, Robert Grützmann, Uwe A. Wittel, Frank Makowiec, Ulrich T. Hopt, Peter Bronsert, Florian Kühn, Bettina M. Rau, Roman E. Izrailov, Igor E. Khatkov, Hryhoriy Lapshyn, Louisa Bolm, Dirk Bausch, Tobias Keck, Ulrich F. Wellner, Gabriel Seifert. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study. Langenbeck's Archives of Surgery 2017; 402(5) doi: 10.1007/s00423-017-1590-9
|
| 79 |
Pierre Bedossa, David E. Kleiner. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; doi: 10.1007/978-3-319-20538-0_12
|
| 80 |
Haejung Kim, Haein Hwang, Hansoo Lee, Hyo Jeong Hong. L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating KRAS Mutation. Molecules and Cells 2017; 40(5) doi: 10.14348/molcells.2017.2282
|
| 81 |
Oliver Clements, Joseph Eliahoo, Jin Un Kim, Simon D. Taylor-Robinson, Shahid A. Khan. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Journal of Hepatology 2020; 72(1) doi: 10.1016/j.jhep.2019.09.007
|
| 82 |
Jung Ho Im, Joon Seong Park, Dong Sup Yoon, Dong Ki Lee, Jun Won Kim, Ik Jae Lee. Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41622-2
|
| 83 |
Samantha M. Ruff, Jordan M. Cloyd, Timothy M. Pawlik. Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers. Annals of Surgical Oncology 2023; 30(13) doi: 10.1245/s10434-023-14255-z
|
| 84 |
HAIXIA YANG, JIUPENG ZHOU, JIANQIANG MI, KE MA, YANGWEI FAN, JING NING, CHUYING WANG, XIN WEI, HUADONG ZHAO, ENXIAO LI. HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma. Oncology Reports 2015; 34(4) doi: 10.3892/or.2015.4194
|
| 85 |
Ubonrat Thamrongwaranggoon, Wunchana Seubwai, Chatchai Phoomak, Sakkarn Sangkhamanon, Ubon Cha'on, Thidarat Boonmars, Sopit Wongkham. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Biochemical and Biophysical Research Communications 2017; 484(2) doi: 10.1016/j.bbrc.2017.01.139
|
| 86 |
Deborah Clark. Painless obstructive jaundice leading to diagnosis of extrahepatic cholangiocarcinoma: a case study and review. Gastrointestinal Nursing 2019; 17(Sup10) doi: 10.12968/gasn.2019.17.Sup10.S22
|
| 87 |
Patrick C. Lee, Andrew Hendifar, Arsen Osipov, May Cho, Daneng Li, Jun Gong. Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations. Cancers 2021; 13(7) doi: 10.3390/cancers13071706
|
| 88 |
Dina G. Tiniakos, João Maurício, Helen L. Reeves. Alcohol and Cancer. Advances in Experimental Medicine and Biology 2018; 1032 doi: 10.1007/978-3-319-98788-0_4
|
| 89 |
Thomas C. Wirth, Arndt Vogel. Surveillance in cholangiocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2016; 30(6) doi: 10.1016/j.bpg.2016.11.001
|
| 90 |
Alastair D Burt, Venâncio Alves, Pierre Bedossa, Andrew Clouston, Maria Guido, Stefan Hübscher, Sanjay Kakar, Irene Ng, Young N Park, Helen Reeves, Judith Wyatt, Matthew M Yeh, David W Ellis. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 2018; 73(3) doi: 10.1111/his.13520
|
| 91 |
Vincenzo Cardinale, Guido Carpino, Lola M. Reid, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: A cancer in search of the right classification. Hepatology 2012; 56(4) doi: 10.1002/hep.25705
|
| 92 |
Ijin Joo, Jeong Min Lee. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdominal Imaging 2013; 38(6) doi: 10.1007/s00261-013-0027-3
|
| 93 |
Marco Silvestri, Trung Nghia Vu, Federico Nichetti, Monica Niger, Serena Di Cosimo, Filippo De Braud, Giancarlo Pruneri, Yudi Pawitan, Stefano Calza, Vera Cappelletti. Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma. Cancer Medicine 2023; 12(8) doi: 10.1002/cam4.5719
|
| 94 |
Xiangguo Tian, Qizhi Wang, Yan Li, Jinhua Hu, Lei Wu, Qian Ding, Chunqing Zhang. The Expression of S100A4 Protein in Human Intrahepatic Cholangiocarcinoma: Clinicopathologic Significance and Prognostic Value. Pathology & Oncology Research 2015; 21(1) doi: 10.1007/s12253-014-9806-6
|
| 95 |
Weiyao Li, Javier Martinez-Useros, Nuria Garcia-Carbonero, Maria J. Fernandez-Aceñero, Luis Ortega-Medina, Sandra Garcia-Botella, Elia Perez-Aguirre, Luis Diez-Valladares, Jesus Garcia-Foncillas. The Prognosis Value of PIWIL1 and PIWIL2 Expression in Pancreatic Cancer. Journal of Clinical Medicine 2019; 8(9) doi: 10.3390/jcm8091275
|
| 96 |
Shahrzad Azizi, Reza Kheirandiah, Masoud Sami. Slaughterhouse report of intrahepatic cholangiocarcinoma in a Holstein cow. Comparative Clinical Pathology 2016; 25(6) doi: 10.1007/s00580-016-2324-z
|
| 97 |
. 2019; doi: 10.70675/d2b2baa8zcc7bz47baz80d8z8ed50f0ad82e
|
| 98 |
Guido Carpino, Vincenzo Cardinale, Paolo Onori, Antonio Franchitto, Pasquale Bartolomeo Berloco, Massimo Rossi, Yunfang Wang, Rossella Semeraro, Maurizio Anceschi, Roberto Brunelli, Domenico Alvaro, Lola M. Reid, Eugenio Gaudio. Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. Journal of Anatomy 2012; 220(2) doi: 10.1111/j.1469-7580.2011.01462.x
|
| 99 |
Jun Kawashima, Miho Akabane, Itaru Endo, Timothy M. Pawlik. Recent advances in the treatment of FGFR-altered cholangiocarcinoma. Expert Opinion on Pharmacotherapy 2025; 26(18) doi: 10.1080/14656566.2025.2605200
|
| 100 |
Miao-Erh Chang, Hao-Jan Lei, Ming-Huang Chen, Yi-Chen Yeh, Chung-Pin Li, Yi-Ping Hung, Cheng-Yuan Hsia, Chieu-An Liu, Gar-Yang Chau, Yee Chao. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. Journal of the Chinese Medical Association 2017; 80(3) doi: 10.1016/j.jcma.2016.09.010
|
| 101 |
Pablo Letelier, Ismael Riquelme, Alfonso Hernández, Neftalí Guzmán, Jorge Farías, Juan Roa. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. International Journal of Molecular Sciences 2016; 17(5) doi: 10.3390/ijms17050791
|
| 102 |
Maen Abdelrahim, Abdullah Esmail, Jiaqiong Xu, Godsfavour Umoru, Hadeel Al-Rawi, Ashish Saharia, Ala Abudayyeh, David Victor, Robert McMillan, Sudha Kodali, Rafik M. Ghobrial. Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.908687
|
| 103 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_29
|
| 104 |
Yan Zhu, Jason A. Wu, Dengyong Zhang, Saikat Chowdhury, Huamin Wang, Sunyoung S. Lee, Funda Meric-Bernstam, Zishuo I. Hu, Milind Javle, Lawrence N. Kwong. Global patterns of mutational profiles in biliary tract cancer. Journal of Hepatology 2026; 85(2) doi: 10.1016/j.jhep.2026.03.029
|
| 105 |
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 2016; 13(5) doi: 10.1038/nrgastro.2016.51
|
| 106 |
Sravanthi Lavu, Terry M. Therneau, William S. Harmsen, Kristin C. Mara, Nicha Wongjarupong, Mohamed Hassan, Hamdi A. Ali, Samuel Antwi, Nasra H. Giama, Katsuyuki Miyabe, Lewis R. Roberts. Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma. Hepatology 2020; 72(4) doi: 10.1002/hep.31146
|
| 107 |
Ashley N. Calder, Mirabelle Q. Peter, John W. Tobias, Nureen H. Mohamad Zaki, Theresa M. Keeley, Timothy L. Frankel, Linda C. Samuelson, Nataliya Razumilava. WNT signaling contributes to the extrahepatic bile duct proliferative response to obstruction in mice. JCI Insight 2025; 10(2) doi: 10.1172/jci.insight.181857
|
| 108 |
Wala Ben Kridis, Tahia Boudawara, Afef Khanfir. Sister Mary Joseph’s nodule revealing cholangiocarcinoma. Frontline Gastroenterology 2023; 14(6) doi: 10.1136/flgastro-2023-102436
|
| 109 |
Gunnar Folprecht, Michael Geißler, Christian Jehn, Diana Lüftner, Helmut Oettle. Facharztwissen Hämatologie Onkologie. 2017; doi: 10.1016/B978-3-437-21214-7.00017-1
|
| 110 |
Tushar Patel. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Gastroenterology 2014; 49(2) doi: 10.1007/s00535-013-0894-y
|
| 111 |
Jae Hyun Kim, Ijin Joo, Jeong Min Lee. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Korean Journal of Radiology 2019; 20(7) doi: 10.3348/kjr.2018.0636
|
| 112 |
Samantha M. Ruff, Timothy M. Pawlik. Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1321683
|
| 113 |
Alberto Félix Chapa-Lobo, Luis Enrique Salgado-Cruz, Alan Alejandro Garza-Cantú, Mauricio David Castaño-Eguía, Fernando Rodríguez-Sotelo, Roy Ismael Villafranca-Andino. Cáncer colorrectal hereditario: presentación sincrónica de cáncer colorrectal y colangiocarcinoma en un paciente con poliposis adenomatosa familiar. Cirujano General 2020; 42(1) doi: 10.35366/92712
|
| 114 |
Thomas von Hahn, Sandra Ciesek, Gerd Wegener, Ruben R. Plentz, Tobias J. Weismüller, Heiner Wedemeyer, Michael P. Manns, Tim F. Greten, Nisar P. Malek. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology 2011; 46(9) doi: 10.3109/00365521.2011.589472
|
| 115 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174154
|
| 116 |
Baasansuren Selenge, Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Chie Takasu, Hiroki Teraoku, Shohei Okikawa, Mitsuo Shimada. Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma. The Journal of Medical Investigation 2023; 70(1.2) doi: 10.2152/jmi.70.160
|
| 117 |
Münevver Yenigül, Emel Başak Gencer Akçok. Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells. ACS Omega 2023; 8(24) doi: 10.1021/acsomega.3c01317
|
| 118 |
Yu Huang, Yang Kong, Lufei Zhang, Tianyu He, Xiaohu Zhou, Yingcai Yan, Linshi Zhang, Dongkai Zhou, Sinan Lu, Jiarong Zhou, Lin Zhou, Haiyang Xie, Shusen Zheng, Weilin Wang. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma. BioMed Research International 2018; 2018 doi: 10.1155/2018/2352139
|
| 119 |
Demis Pitoni, Arianna Dal Buono, Roberto Gabbiadini, Vincenzo Ronca, Francesca Colapietro, Nicola Pugliese, Davide Giuseppe Ribaldone, Cristina Bezzio, Ana Lleo, Alessandro Armuzzi. Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Cancers 2025; 17(13) doi: 10.3390/cancers17132165
|
| 120 |
Tueanjai Khunluck, Veerapol Kukongviriyapan, Anucha Puapairoj, Narong Khuntikeo, Laddawan Senggunprai, Ponsilp Zeekpudsa, Auemduan Prawan. Association of NRF2 Polymorphism with Cholangiocarcinoma Prognosis in Thai Patients. Asian Pacific Journal of Cancer Prevention 2014; 15(1) doi: 10.7314/APJCP.2014.15.1.299
|
| 121 |
Seesai Yeesoonsang, Surichai Bilheem, Edward McNeil, Sophon Iamsirithaworn, Chuleeporn Jiraphongsa, Hutcha Sriplung. Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method. Cancer Research and Treatment 2017; 49(1) doi: 10.4143/crt.2016.045
|
| 122 |
Michela Squadroni, Luca Tondulli, Gemma Gatta, Stefania Mosconi, Giordano Beretta, Roberto Labianca. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2017; 116 doi: 10.1016/j.critrevonc.2016.11.012
|
| 123 |
Wanjing Zheng, Hongjie Huang, Dejun She, Meilian Xiong, Xiaodan Chen, Xiaojun Lin, Dairong Cao. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M. Abdominal Radiology 2022; 47(3) doi: 10.1007/s00261-021-03380-6
|
| 124 |
Zhencheng Zhu, Tao Jiang, Qiuhua Liu, Bo Zhang, Gang Wang, Pin Huang, Yue Liu, Dingtao Hu, Ke Guo. Single-cell and spatial multi-omics combined with machine learning to unravel the heterogeneity of cholangiocarcinoma and the WFDC3-mediated prognostic regulatory mechanisms. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1903609
|
| 125 |
M. C. Reichert, G. Farmakis, R. M. Bohle, F. Lammert, V. Zimmer. Cholangiocarcinoma Presenting as Sister Mary Joseph’s Nodule: Case Report and Short Review of the Literature. Journal of Gastrointestinal Cancer 2014; 45(2) doi: 10.1007/s12029-013-9502-x
|
| 126 |
Vincenzo Cardinale, Maria Consiglia Bragazzi, Guido Carpino, Alessia Torrice, Yunfang Wang, Lola McAdams Reid, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinomas: New Insights from the Discovery of Stem Cell Niches in Peribiliary Glands of the Biliary Tree. Advances in Hepatology 2014; 2014 doi: 10.1155/2014/794953
|
| 127 |
Andrea Farioli, Kurt Straif, Giovanni Brandi, Stefania Curti, Kristina Kjaerheim, Jan Ivar Martinsen, Pär Sparen, Laufey Tryggvadottir, Elisabete Weiderpass, Guido Biasco, Francesco Saverio Violante, Stefano Mattioli, Eero Pukkala. Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case–control study in four Nordic countries. Occupational and Environmental Medicine 2018; 75(3) doi: 10.1136/oemed-2017-104603
|
| 128 |
Domenico Alvaro. Progranulin and cholangiocarcinoma: another bad boy on the block!. Gut 2012; 61(2) doi: 10.1136/gutjnl-2011-301518
|
| 129 |
Aaron J. Scott, Reya Sharman, Rachna T. Shroff. Precision Medicine in Biliary Tract Cancer. Journal of Clinical Oncology 2022; 40(24) doi: 10.1200/JCO.21.02576
|
| 130 |
Surya K. De. Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth
Factor Receptors for Treatment of the Bile Duct Cancer. Current Medicinal Chemistry 2024; 31(6) doi: 10.2174/0929867330666230416152913
|
| 131 |
|
| 132 |
Natthawan Kittiratphatthana, Veerapol Kukongviriyapan, Auemduan Prawan, Laddawan Senggunprai. Luteolin induces cholangiocarcinoma cell apoptosis through the mitochondrial-dependent pathway mediated by reactive oxygen species. Journal of Pharmacy and Pharmacology 2016; 68(9) doi: 10.1111/jphp.12586
|
| 133 |
Qiao Wu, Hua Fan, Ren Lang, Xianliang Li, Xingmao Zhang, Shaocheng Lv, Qiang He, Jialiang Yang. [Retracted] Overexpression of 14‐3‐3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/3740418
|
| 134 |
Fan Lin, Jianhui Shi, Hanlin L Wang, Xiao-Jun Ma, Robert Monroe, Yuling Luo, Zongming Chen, Haiyan Liu. Detection of Albumin Expression by RNA In Situ Hybridization Is a Sensitive and Specific Method for Identification of Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas. American Journal of Clinical Pathology 2018; 150(1) doi: 10.1093/ajcp/aqy030
|
| 135 |
Tueanjai Khunluck, Ingon Inson, Chartinun Chutoe, Laddawan Senggunprai, Auemduan Prawan, Kornkamon Lertsuwan. Brusatol enhances the chemotherapy efficacy of Cisplatin and Gemcitabine in KKU-100 cholangiocarcinoma cells through ROS-mediated apoptosis. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-59031-7
|
| 136 |
Heather A. Lillemoe, John D. Abad, Keith D. Lillemoe. Pancreatic Cancer. 2017; doi: 10.1007/978-1-4939-6631-8_10-2
|
| 137 |
Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo, Karen Zhang, Apurva Jain, Anaemy Danner De Armas, Stephanie Reyes, Tri Minh Le, Osama E Rahma, Jennifer Stanton, Thomas T DeLeon, Marc Roth, Mary Linton B Peters, Andrew X Zhu, Jochen K Lennerz, A John Iafrate, Kylie Boyhen, Christine VanCott, Lewis R Roberts, Stacie Lindsey, Nora Horick, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Robin Kate Kelley, Milind M Javle, Lipika Goyal. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. JNCI: Journal of the National Cancer Institute 2023; 115(7) doi: 10.1093/jnci/djad046
|
| 138 |
Yuan Gao, Yi Liu, Li Sun, Xiwu Ouyang, Chunfu Zhu, Xihu Qin. MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma. Genetic Testing and Molecular Biomarkers 2021; 25(11) doi: 10.1089/gtmb.2021.0122
|
| 139 |
Juan Putra, Francine B. de Abreu, Jason D. Peterson, J. Marc Pipas, Kabir Mody, Christopher I. Amos, Gregory J. Tsongalis, Arief A. Suriawinata. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing. Experimental and Molecular Pathology 2015; 99(2) doi: 10.1016/j.yexmp.2015.07.005
|
| 140 |
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver. 2018; doi: 10.1016/B978-0-7020-6697-9.00005-4
|
| 141 |
Udayakumar Navaneethan, Mansour A. Parsi, Vennisvasanth Lourdusamy, Amit Bhatt, Norma G. Gutierrez, David Grove, Madhusudhan R. Sanaka, Jeffrey P. Hammel, Tyler Stevens, John J. Vargo, Raed A. Dweik. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study. Gastrointestinal Endoscopy 2015; 81(4) doi: 10.1016/j.gie.2014.09.041
|
| 142 |
Michael Tayao, Juliana Andrici, Mahtab Farzin, Adele Clarkson, Loretta Sioson, Nicole Watson, Terence C Chua, Tamara Sztynda, Jaswinder S Samra, Anthony J Gill, Pankaj K Singh. Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma. PLOS ONE 2016; 11(3) doi: 10.1371/journal.pone.0150338
|
| 143 |
Aline Lopes CHAGAS, Angelo Alves de MATTOS, Flair José CARRILHO, Paulo Lisboa BITTENCOURT, Denise Cerqueira Paranaguá VEZOZZO, Natally HORVAT, Manoel de Souza ROCHA, Venâncio Avancini Ferreira ALVES, Gabriela Perdomo CORAL, Mario Reis ALVARES-DA-SILVA, Fabio Marinho do Rego BARROS, Marcos Roberto MENEZES, Lucas Moretti MONSIGNORE, Fabricio Ferreira COELHO, Renato Ferreira da SILVA, Rita de Cássia Martins Alves SILVA, Ilka de Fatima Santana Ferreira BOIN, Luiz Augusto Carneiro D`ALBUQUERQUE, José Huygens Parente GARCIA, Guilherme Eduardo Gonçalves FELGA, Airton Mota MOREIRA, Maria Ignez Freitas Melro BRAGHIROLI, Paulo Marcelo Gehm HOFF, Vivianne Barretto de MELLO, Mariana Fonseca DOTTORI, Tiago Pugliese BRANCO, Leonardo de Lucca SCHIAVON, Thaisa de Fátima Almeida COSTA. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA. Arquivos de Gastroenterologia 2020; 57(suppl 1) doi: 10.1590/s0004-2803.202000000-20
|
| 144 |
Zhenyang Shen, Jingbo Xiao, Junjun Wang, Lungen Lu, Xinjian Wan, Xiaobo Cai. Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01471-0
|
| 145 |
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer, Luay Ali Khaleel, Sada Jasim Abdulameer, Ameer Mezher Hadi, Muna. S Merza, Rahman S. Zabibah, Ahmed Ali. Small but mighty: How microRNAs drive the deadly progression of cholangiocarcinoma. Pathology - Research and Practice 2023; 247 doi: 10.1016/j.prp.2023.154565
|
| 146 |
Heather A. Lillemoe, John D. Abad, Keith D. Lillemoe. Pancreatic Cancer. 2018; doi: 10.1007/978-1-4939-7193-0_10
|
| 147 |
Estanislao Peixoto, Sujeong Jin, Kristen Thelen, Aalekhya Biswas, Seth Richard, Manuela Morleo, Adrian Mansini, Stephanie Holtorf, Fabrizia Carbone, Nunzia Pastore, Andrea Ballabio, Brunella Franco, Sergio A. Gradilone. HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(6) doi: 10.1152/ajpgi.00033.2020
|
| 148 |
Kevin Verhoeff, Julinor Bacani, Christopher Fung, Laura A. Canterbury. A Cholangioblastic Variant of Cholangiocarcinoma. ACG Case Reports Journal 2022; 9(2) doi: 10.14309/crj.0000000000000746
|
| 149 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_29-1
|
| 150 |
Steven Koprowski, Kevin Sokolowski, Selvi Kunnimalaiyaan, T. Clark Gamblin, Muthusamy Kunnimalaiyaan. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma. Journal of Surgical Research 2015; 198(2) doi: 10.1016/j.jss.2015.03.029
|
| 151 |
Vincenzo Cardinale, Guido Carpino, Lola Reid, Eugenio Gaudio, Domenico Alvaro. Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. World Journal of Gastrointestinal Oncology 2012; 4(5): 94-102 doi: 10.4251/wjgo.v4.i5.94
|
| 152 |
Hector Perez-Montoyo. Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma. Cells 2020; 9(3) doi: 10.3390/cells9030614
|
| 153 |
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt, Alastair D. Burt. MacSween's Pathology of the Liver. 2024; doi: 10.1016/B978-0-7020-8228-3.00005-3
|
| 154 |
Suk-young Lee, Hye sook Kim, Yoon Ji Choi, Kyong Hwa Park, Sang Won Shin, Yeul Hong Kim, Seung Tae Kim. A Prognostic Index to Identify Patients With Intrahepatic Cholangiocarcinoma Who Could Benefit From Gemcitabine Plus Cisplatin. American Journal of Therapeutics 2016; 23(6) doi: 10.1097/MJT.0000000000000112
|
| 155 |
Alexander Ney, Andres Garcia-Sampedro, George Goodchild, Pilar Acedo, Giuseppe Fusai, Stephen P. Pereira. Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic Conundrum. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.699401
|
| 156 |
Hayat Khizar, Yufei Hu, Yanhua Wu, Jianfeng Yang. The role and implication of autophagy in cholangiocarcinoma. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01631-7
|
| 157 |
Cyril Dalmasso, Wassila Carpentier, Catherine Guettier, Sophie Camilleri-Broët, Wyllians Vendramini Borelli, Cedália Rosane Campos dos Santos, Denis Castaing, Jean-Charles Duclos-Vallée, Philippe Broët. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1111-6
|
| 158 |
Francesca Saffioti, Davide Roccarina, Mette Vesterhus, Johannes R. Hov, William Rosenberg, Massimo Pinzani, Stephen P. Pereira, Kirsten M. Boberg, Douglas Thorburn. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis. European Journal of Clinical Investigation 2019; 49(5) doi: 10.1111/eci.13088
|
| 159 |
Jun Li, Mohamed Moustafa, Michael Linecker, Georg Lurje, Ivan Capobianco, Janine Baumgart, Francesca Ratti, Falk Rauchfuss, Deniz Balci, Eduardo Fernandes, Roberto Montalti, Ricardo Robles-Campos, Bergthor Bjornsson, Stefan A. Topp, Jiri Fronek, Chao Liu, Roger Wahba, Christiane Bruns, Stefan M. Brunner, Hans J. Schlitt, Asmus Heumann, Björn-Ole Stüben, Jakob R. Izbicki, Jan Bednarsch, Enrico Gringeri, Elisa Fasolo, Jens Rolinger, Jakub Kristek, Roberto Hernandez-Alejandro, Andreas Schnitzbauer, Natascha Nuessler, Michael R. Schön, Sergey Voskanyan, Athanasios S. Petrou, Oszkar Hahn, Yuji Soejima, Emilio Vicente, Carlos Castro-Benitez, René Adam, Federico Tomassini, Roberto Ivan Troisi, Alexandros Kantas, Karl Juergen Oldhafer, Victoria Ardiles, Eduardo de Santibanes, Massimo Malago, Pierre-Alain Clavien, Marco Vivarelli, Utz Settmacher, Luca Aldrighetti, Ulf Neumann, Henrik Petrowsky, Umberto Cillo, Hauke Lang, Silvio Nadalin. ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study. Annals of Surgical Oncology 2020; 27(5) doi: 10.1245/s10434-019-08192-z
|
| 160 |
B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, F Klauschen, K Joehrens, A Warth, M Renner, A Mehrabi, M Hafezi, A Thelen, P Schirmacher, W Weichert. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. British Journal of Cancer 2013; 109(10) doi: 10.1038/bjc.2013.610
|
| 161 |
Lawagoulé Joseph Emile Ky, Eric Hervé Mourfou, Abdoul Fatao Maïga, Daouda Sangaré, Damien Marcel Traoré, Saïdou Santi, Madina Koanda, Alimata Sanfo, Delphine Napon/Zongo, Aboubacar Coulibaly, Kounpiélimé Sosthène Somda, Arsène Roger Sombié. Sister Mary Joseph's Nodule Revealing Klatskin's Cholangiocarcinoma at the Yalgado Ouedraogo University Hospital: Case Report and Literature Review. Clinical Case Reports 2025; 13(10) doi: 10.1002/ccr3.71337
|
| 162 |
Paxton V. Dickson, Stephen W. Behrman. Distal Cholangiocarcinoma. Surgical Clinics of North America 2014; 94(2) doi: 10.1016/j.suc.2013.12.004
|
| 163 |
Eiko Nishioka, Masakatsu Tsurusaki, Ryohei Kozuki, Sung-Woon Im, Atsushi Kono, Kazuhiro Kitajima, Takamichi Murakami, Kazunari Ishii. Comparison of Conventional Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnostic Accuracy of Staging in Patients with Intrahepatic Cholangiocarcinoma. Diagnostics 2022; 12(11) doi: 10.3390/diagnostics12112889
|
| 164 |
Austin G. Duffy, Oxana V. Makarova‐Rusher, Tim F. Greten. The case for immune‐based approaches in biliary tract carcinoma. Hepatology 2016; 64(5) doi: 10.1002/hep.28635
|
| 165 |
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Emilio Di Giulio, Giuseppe Tonini, Francesco Pantano, Rosanna Venere, Maria Consiglia Bragazzi, Francesca Biancanello, Jessica Faccioli, Aurora Giannetti, Marcello Cintolo, Michela Di Giunta, Martina Gambato, Alberto Lasagni, Francesco Izzo, Antonio Avallone, Jesus Banales, Massimo Rossi, Carlo Catalano, Andrea Laghi, Giulia D'amati, Maria Grazia Mancino, Lorenzo Ridola. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging. Digestive and Liver Disease 2020; 52(11) doi: 10.1016/j.dld.2020.06.045
|
| 166 |
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; doi: 10.1007/978-3-642-40558-7_7
|
| 167 |
Tsunekazu Oikawa, Eliane Wauthier, Timothy A. Dinh, Sara R. Selitsky, Andrea Reyna-Neyra, Guido Carpino, Ronald Levine, Vincenzo Cardinale, David Klimstra, Eugenio Gaudio, Domenico Alvaro, Nancy Carrasco, Praveen Sethupathy, Lola M. Reid. Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells. Nature Communications 2015; 6(1) doi: 10.1038/ncomms9070
|
| 168 |
|